More Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class A news
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class ASSE: 600613

"Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd."Semi-annual Report for 2026

Aug 29, 2026 · Issued by Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class A via Shanghai Stock Exchange
Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class A

  • "Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd."Indicative Announcement on Abnormal Fluctuations in Stock Trading and RisksAug 25
  • "Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd."Announcement on Risk Warning in Stock TradingAug 21
  • "Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd."Announcement on Abnormal Fluctuations in Stock TradingAug 20
  • "Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd."Indicative Announcement on Equity Change of Persons Acting in Concert with the Controlling Shareholder Reaching 1% ThresholdAug 13
All Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Class A news releases↗